focus -WSS

focus

author：knowledge 2025-09-30 17:30:10 - browse：65

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Readers discuss the intersection of pregnancy and addiction

knowledge

WSS

How to ethically and practically extend health care to all

Cigna wins case to block Amy Bricker's move to CVS

Flint parents haunted by uncertainty, fears of lead poisoning

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

It costs an awful lot of money to give away a kidney

Pharma showers House GOP doctor with campaign cash

hotspot

focus

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Heart disease in astronauts blamed on cosmic radiation

Drug repurposing or repositioning? The language matters

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Trump demands the U.S. pay no more for drugs than other countries … again

Study: Why relieving medical debt did not improve financial outcomes

Wildfire smoke exposes gaps in outdoor worker protections

Teladoc has a new CEO, but challenges remain the same

ChatGPT in medicine: STAT answers readers' burning questions

Cigna wins case to block Amy Bricker's move to CVS

leisure time

Flint parents haunted by uncertainty, fears of lead poisoning

'Essentially witchcraft:' A former naturopath takes on the field

Readers discuss the intersection of pregnancy and addiction

Chris Christie meets with Zelenskyy during Ukraine trip

Study links childhood stress with decline in older age

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

knowledge

hotspot

leisure time

leisure time